ESR1 mutations were detected at very low allele frequencies in some primary breast cancers, and at high allele frequency in patients withmetastatic breast cancer. ESR1-mutant clones are enriched by endocrine therapy. This evidence concerns the gene ESR1 and breast carcinoma.